Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo

Kermit V Speeg, A. L. Maldonado, J. Liaci, D. Muirhead

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The multidrug resistance (MDR) transport protein is a normal constituent of proximal renal tubules although its function has not been defined in vivo. We find that colchicine, an MDR substrate, is secreted into urine by a process which is distinct from the organic cation transporter responsible for tetraethylammonium and N-methylnicotinamide secretion. Cyclosporine (CsA), which reverses MDR in vitro presumably by inhibiting the MDR transporter, inhibits colchicine renal secretion but does not inhibit the net secretion of the organic cation, ranitidine, or the organic anion, p-aminohippurate. After CsA (2 mg/kg i.v.), colchicine renal clearance decreased from 6.23 ± 0.46 to 3.58 ± 0.31 ml/min · kg (P < .05), glomerular filtration rate was unchanged (4.21 ± 0.08 and 3.88 ± 0.17 ml/min · kg, before and after CsA, respectively; P = .09) and colchicine secretory ratio decreased from 1.48 ± 0.11 to 0.92 ± 0.07 (P < .05). Cremophor (CsA vehicle) increased colchicine renal clearance (6.77 ± 0.29 to 7.7 ± 0.3 ml/min · kg, P < .05) and colchicine secretory ratio (1.425 ± 0.071 to 1.621 ± 0.061, P < .05). The inhibition of colchicine secretion was long-lived lasting at least 30 hr after CsA. Thus, colchicine is actively secreted into urine by the multidrug transporter in vivo. CsA profoundly inhibits colchicine secretion into urine while having no effect on the secretion of the organic cation ranitidine or the organic anion p-aminohippurate.

Original languageEnglish (US)
Pages (from-to)50-55
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume261
Issue number1
StatePublished - 1992

Fingerprint

Colchicine
Cyclosporine
Kidney
Multiple Drug Resistance
p-Aminohippuric Acid
Cations
Ranitidine
Urine
Anions
P-Glycoproteins
Proximal Kidney Tubule
Tetraethylammonium
Glomerular Filtration Rate
Carrier Proteins

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo. / Speeg, Kermit V; Maldonado, A. L.; Liaci, J.; Muirhead, D.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 261, No. 1, 1992, p. 50-55.

Research output: Contribution to journalArticle

@article{663dbdf31eb74e7490a140aeef1a10c6,
title = "Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo",
abstract = "The multidrug resistance (MDR) transport protein is a normal constituent of proximal renal tubules although its function has not been defined in vivo. We find that colchicine, an MDR substrate, is secreted into urine by a process which is distinct from the organic cation transporter responsible for tetraethylammonium and N-methylnicotinamide secretion. Cyclosporine (CsA), which reverses MDR in vitro presumably by inhibiting the MDR transporter, inhibits colchicine renal secretion but does not inhibit the net secretion of the organic cation, ranitidine, or the organic anion, p-aminohippurate. After CsA (2 mg/kg i.v.), colchicine renal clearance decreased from 6.23 ± 0.46 to 3.58 ± 0.31 ml/min · kg (P < .05), glomerular filtration rate was unchanged (4.21 ± 0.08 and 3.88 ± 0.17 ml/min · kg, before and after CsA, respectively; P = .09) and colchicine secretory ratio decreased from 1.48 ± 0.11 to 0.92 ± 0.07 (P < .05). Cremophor (CsA vehicle) increased colchicine renal clearance (6.77 ± 0.29 to 7.7 ± 0.3 ml/min · kg, P < .05) and colchicine secretory ratio (1.425 ± 0.071 to 1.621 ± 0.061, P < .05). The inhibition of colchicine secretion was long-lived lasting at least 30 hr after CsA. Thus, colchicine is actively secreted into urine by the multidrug transporter in vivo. CsA profoundly inhibits colchicine secretion into urine while having no effect on the secretion of the organic cation ranitidine or the organic anion p-aminohippurate.",
author = "Speeg, {Kermit V} and Maldonado, {A. L.} and J. Liaci and D. Muirhead",
year = "1992",
language = "English (US)",
volume = "261",
pages = "50--55",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo

AU - Speeg, Kermit V

AU - Maldonado, A. L.

AU - Liaci, J.

AU - Muirhead, D.

PY - 1992

Y1 - 1992

N2 - The multidrug resistance (MDR) transport protein is a normal constituent of proximal renal tubules although its function has not been defined in vivo. We find that colchicine, an MDR substrate, is secreted into urine by a process which is distinct from the organic cation transporter responsible for tetraethylammonium and N-methylnicotinamide secretion. Cyclosporine (CsA), which reverses MDR in vitro presumably by inhibiting the MDR transporter, inhibits colchicine renal secretion but does not inhibit the net secretion of the organic cation, ranitidine, or the organic anion, p-aminohippurate. After CsA (2 mg/kg i.v.), colchicine renal clearance decreased from 6.23 ± 0.46 to 3.58 ± 0.31 ml/min · kg (P < .05), glomerular filtration rate was unchanged (4.21 ± 0.08 and 3.88 ± 0.17 ml/min · kg, before and after CsA, respectively; P = .09) and colchicine secretory ratio decreased from 1.48 ± 0.11 to 0.92 ± 0.07 (P < .05). Cremophor (CsA vehicle) increased colchicine renal clearance (6.77 ± 0.29 to 7.7 ± 0.3 ml/min · kg, P < .05) and colchicine secretory ratio (1.425 ± 0.071 to 1.621 ± 0.061, P < .05). The inhibition of colchicine secretion was long-lived lasting at least 30 hr after CsA. Thus, colchicine is actively secreted into urine by the multidrug transporter in vivo. CsA profoundly inhibits colchicine secretion into urine while having no effect on the secretion of the organic cation ranitidine or the organic anion p-aminohippurate.

AB - The multidrug resistance (MDR) transport protein is a normal constituent of proximal renal tubules although its function has not been defined in vivo. We find that colchicine, an MDR substrate, is secreted into urine by a process which is distinct from the organic cation transporter responsible for tetraethylammonium and N-methylnicotinamide secretion. Cyclosporine (CsA), which reverses MDR in vitro presumably by inhibiting the MDR transporter, inhibits colchicine renal secretion but does not inhibit the net secretion of the organic cation, ranitidine, or the organic anion, p-aminohippurate. After CsA (2 mg/kg i.v.), colchicine renal clearance decreased from 6.23 ± 0.46 to 3.58 ± 0.31 ml/min · kg (P < .05), glomerular filtration rate was unchanged (4.21 ± 0.08 and 3.88 ± 0.17 ml/min · kg, before and after CsA, respectively; P = .09) and colchicine secretory ratio decreased from 1.48 ± 0.11 to 0.92 ± 0.07 (P < .05). Cremophor (CsA vehicle) increased colchicine renal clearance (6.77 ± 0.29 to 7.7 ± 0.3 ml/min · kg, P < .05) and colchicine secretory ratio (1.425 ± 0.071 to 1.621 ± 0.061, P < .05). The inhibition of colchicine secretion was long-lived lasting at least 30 hr after CsA. Thus, colchicine is actively secreted into urine by the multidrug transporter in vivo. CsA profoundly inhibits colchicine secretion into urine while having no effect on the secretion of the organic cation ranitidine or the organic anion p-aminohippurate.

UR - http://www.scopus.com/inward/record.url?scp=0026636982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026636982&partnerID=8YFLogxK

M3 - Article

C2 - 1348538

AN - SCOPUS:0026636982

VL - 261

SP - 50

EP - 55

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -